首頁 > 市場調查報告書 > 製藥

疫苗感染疾病

市場調查報告書

商品編碼

1498656

全球炭疽疫苗市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Anthrax Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到2032年，全球炭疽疫苗市場需求將從2023年的167.3億美元達到近281.6億美元的市場規模，2024-2032年研究期間的複合年成長率為5.96%。

炭疽疫苗是一種生物製劑，可提供針對引起炭疽的炭疽桿菌的免疫力。它主要用於高暴露風險的個人，例如軍事人員、實驗室工作人員和處理動物產品的個人。該疫苗以免疫系統為目標，產生針對細菌保護性抗原的抗體，從而提供針對感染的防禦。它是生物防禦和職業健康計劃的重要組成部分。

市場動態

生物恐怖主義和生物戰的持續威脅，加上炭疽自然爆發的可能性，凸顯了炭疽疫苗接種作為公共衛生防範措施的至關重要性。這提高了人們對炭疽作為潛在生物安全威脅的認知，促使政府機構和國防組織儲存炭疽疫苗並投資疫苗接種計劃，從而提振了市場需求。疫苗開發和製造技術的進步促進了下一代炭疽疫苗的開發，其安全性得到改善，功效增強，劑量方案減少，從而推動了市場的採用和擴張。此外，增加政府對生物防禦計劃和新出現的傳染病的資助和研究撥款，透過支持疫苗研究和開發工作來刺激市場成長。

此外，不斷擴大的全球旅行和貿易網路增加了炭疽傳播和傳播的風險，推動了高風險地區和高風險族群（例如軍事人員、急救人員和實驗室工作人員）對炭疽疫苗的需求。此外，製藥公司、政府機構和研究機構之間的策略夥伴關係和合作促進了疫苗生產的可擴展性、法規核准和全球分銷，從而促進了市場成長。然而，潛在的副作用和有限的意識可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球炭疽疫苗市場的各個細分市場進行了包容性評估。炭疽疫苗產業的成長和趨勢為本研究提供了整體方法。

市場區隔

炭疽疫苗市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

無細胞 PA 疫苗（吸收炭疽疫苗 (AVA)、沉澱炭疽疫苗 (AVP)）
減毒活疫苗

按申請

獸醫用途
人類使用

按最終用途

獸醫醫院和診所
醫院及診所
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲炭疽疫苗市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。炭疽疫苗市場的主要參與者包括Altimmune Inc.、Agrovet、Bayer AG、Bavarian Nordic、Biogenesis Bago SA、Ceva Sante Animale、Colondo Serum Company、Emergent BioSolutions、Elusys Therapeutics Inc.、IndianImmunologicals Ltd.、Solutions、Elusys Therapeutics Inc.、IndianImmunologicals Ltd.、Intervac (PVT) Ltd、 JOVAC、Merck Co Inc.、Proton Biopharma Ltd。和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：炭疽疫苗公司的競爭格局

炭疽疫苗市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Altimmune Inc.

公司簡介
公司收入
產品
最近的發展

Agrovet

公司簡介
公司收入
產品
最近的發展

Bayer AG

公司簡介
公司收入
產品
最近的發展

Bavarian Nordic

公司簡介
公司收入
產品
最近的發展

Biogenesis Bago SA

公司簡介
公司收入
產品
最近的發展

Ceva Sante Animale

公司簡介
公司收入
產品
最近的發展

Colondo Serum Company

公司簡介
公司收入
產品
最近的發展

Emergent BioSolutions

公司簡介
公司收入
產品
最近的發展

Elusys Therapeutics Inc.

公司簡介
公司收入
產品
最近的發展

Indian Immunologicals Ltd.

公司簡介
公司收入
產品
最近的發展

Intervac (PVT) Ltd

公司簡介
公司收入
產品
最近的發展

JOVAC

公司簡介
公司收入
產品
最近的發展

Merck Co Inc.

公司簡介
公司收入
產品
最近的發展

Proton Biopharma Ltd

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114768

The global demand for Anthrax Vaccine Market is presumed to reach the market size of nearly USD 28.16 Billion by 2032 from USD 16.73 Billion in 2023 with a CAGR of 5.96% under the study period 2024-2032.

The anthrax vaccine is a biological preparation that provides immunity against Bacillus anthracis, which causes anthrax. It is primarily used for individuals at high risk of exposure, such as military personnel, laboratory workers, and individuals handling animal products. The vaccine targets the immune system to generate antibodies against the bacterium's protective antigen, thereby providing defense against infection. It is a crucial component in biodefense and occupational health programs.

MARKET DYNAMICS

The persistent threat of bioterrorism and biological warfare, coupled with the potential for natural outbreaks of anthrax, underscores the critical importance of anthrax vaccination as a public health preparedness measure. This heightened awareness of anthrax as a potential biosecurity threat drives government agencies and defense organizations to stockpile anthrax vaccines and invest in vaccination programs, bolstering market demand. Advancements in vaccine development and manufacturing technologies have led to the development of next-generation anthrax vaccines with improved safety profiles, enhanced efficacy, and reduced dosage regimens, driving market adoption and expansion. Additionally, increasing government funding and research grants for biodefense initiatives and emerging infectious diseases stimulate market growth by supporting vaccine research and development efforts.

Moreover, expanding global travel and trade networks increase the risk of anthrax transmission and dissemination, driving demand for anthrax vaccines in high-risk regions and among at-risk populations, such as military personnel, first responders, and laboratory workers. Furthermore, strategic partnerships and collaborations between pharmaceutical companies, government agencies, and research institutions facilitate vaccine production scalability, regulatory approvals, and global distribution, fostering market growth. However, potential side effects and limited awareness may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Anthrax Vaccine. The growth and trends of Anthrax Vaccine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Anthrax Vaccine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Cell Free PA Vaccine (Anthrax Vaccine Absorbed (AVA), Anthrax Vaccine Precipitated (AVP))
Live Attenuated Vaccine

By Application

Veterinary Use
Human Use

By End-use

Veterinary Hospitals & Clinics
Hospital & Clinics
Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Anthrax Vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Anthrax Vaccine market include Altimmune Inc., Agrovet, Bayer AG, Bavarian Nordic, Biogenesis Bago SA, Ceva Sante Animale, Colondo Serum Company, Emergent BioSolutions, Elusys Therapeutics Inc., Indian Immunologicals Ltd., Intervac (PVT) Ltd, JOVAC, Merck Co Inc., Proton Biopharma Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANTHRAX VACCINE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTHRAX VACCINE MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Cell Free PA Vaccine (Anthrax Vaccine Absorbed (AVA), Anthrax Vaccine Precipitated (AVP)) Historic and Forecast Sales By Regions
5.4. Live Attenuated Vaccine Historic and Forecast Sales By Regions

6. GLOBAL ANTHRAX VACCINE MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Veterinary Use Historic and Forecast Sales By Regions
6.4. Human Use Historic and Forecast Sales By Regions

7. GLOBAL ANTHRAX VACCINE MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Veterinary Hospitals & Clinics Historic and Forecast Sales By Regions
7.4. Hospital & Clinics Historic and Forecast Sales By Regions
7.5. Other Historic and Forecast Sales By Regions

8. GLOBAL ANTHRAX VACCINE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ANTHRAX VACCINE COMPANIES

9.1. Anthrax Vaccine Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ANTHRAX VACCINE INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Altimmune Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Agrovet
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Bayer AG
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Bavarian Nordic
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Biogenesis Bago SA
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Ceva Sante Animale
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Colondo Serum Company
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Emergent BioSolutions
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Elusys Therapeutics Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Indian Immunologicals Ltd.
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Intervac (PVT) Ltd
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. JOVAC
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Merck Co Inc.
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. Proton Biopharma Ltd
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Type (USD MN)
Cell Free PA Vaccine (Anthrax Vaccine Absorbed (AVA), Anthrax Vaccine Precipitated (AVP)) Market Sales By Geography (USD MN)
Live Attenuated Vaccine Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Veterinary Use Market Sales By Geography (USD MN)
Human Use Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Veterinary Hospitals & Clinics Market Sales By Geography (USD MN)
Hospital & Clinics Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Global Anthrax Vaccine Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Anthrax Vaccine Report
Market Research Process
Market Research Methodology
Global Anthrax Vaccine Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Type
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Type (USD MN)
Cell Free PA Vaccine (Anthrax Vaccine Absorbed (AVA), Anthrax Vaccine Precipitated (AVP)) Market Sales By Geography (USD MN)
Live Attenuated Vaccine Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Veterinary Use Market Sales By Geography (USD MN)
Human Use Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Veterinary Hospitals & Clinics Market Sales By Geography (USD MN)
Hospital & Clinics Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis